Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Merck Expands Distribution Agreement with Public Health England
2017-06-15 20:00
Merck Awarded its First CRISPR Patent by Australian Patent Office
2017-06-14 20:00
Croma-Pharma Announces Two Major Milestones in China
2017-06-13 21:22
New LEADER Analysis Shows Victoza(R) Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events
2017-06-13 09:30
Tresiba® Demonstrated No Increased Risk Of Major Cardiovascular Events and Significant Reduction in Rates of Severe Hypoglycaemia Compared to Insulin Glargine U100 in the DEVOTE Trial
2017-06-13 05:15
Switching to Tresiba® Provides Significant Reductions in Blood Glucose and Lower Rates of Hypoglycaemia in a Real-world Setting
2017-06-11 01:00
Shineco, Inc. Enters into Strategic Cooperation Agreement to Establish the Institute of Chinese Apocynum Industrial Technology Research
2017-06-09 20:00
Ascensia Diabetes Care and Voluntis Announce Technology Partnership to Help Optimize Insulin Management for People With Type 2 Diabetes
2017-06-09 15:42
The Scripps Research Institute and ShangPharma Innovation Announce Translational Research Collaboration
2017-06-08 23:00
Tekni-Plex announces $15 million investment in new China manufacturing facility
2017-06-08 20:00
European NGS Service Providers Prepare to Leverage Growing Demand for Exome and RNA Sequencing
2017-06-08 16:43
Aptuit Announces Strategic Provider Agreement with Regulus Therapeutics
2017-06-08 08:00
ShangPharma Innovation Names New Executives-In-Residence
2017-06-07 23:00
CARsgen Presents Phase I Results of CAR-GPC3 T HCC Trial at ASCO 2017 Annual Meeting
2017-06-05 14:30
NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project
2017-06-01 19:52
NLS Pharma Unveils Positive Phase 2 Data For NLS-1 (mazindol CR) In Adults With ADHD, Demonstrating Significant Improvement In Symptoms
2017-05-31 19:00
Financial Incentives, Physician Awareness, and Regulatory Support Boost Biosimilars Market in Europe
2017-05-31 18:34
Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
2017-05-31 02:31
OrphoMed Secures $39 Million Series A Financing Round
2017-05-29 07:00
ShangPharma Innovation Appoints Mohamad Moghadam-Tabrizi as Senior Vice President of Business Development
2017-05-24 23:00
1
373
374
375
376
377
412